Chikungunya, the emerging migratory rheumatism

Mapping Zika virus disease incidence in Valle del Cauca

“…Methods Surveillance cases data of the ongoing epidemic of ZIKV in Valle del Cauca department and its capital, Cali (2015-2016), were used to estimate cumulated incidence rates (cases/100,000 population) to develop the first maps in the department and it municipalities. The GIS software 1 3 of dengue and chikungunya (CHIKV) have occurred, and from where concomitant co-circulation of those arboviruses may occur [2,3]. Nevertheless, it is important to notice that there is not epidemic of dengue and chikungunya during the current epidemic of Zika in Colombia.…”

Zika: the new arbovirus threat for Latin America

“…In other countries of Latin America, where the existence of Aedes mosquitoes is endemic and dengue has been transmitted for decades and since the end of 2013 also chikungunya was reported [9], doubts about the ability to control of these arboviral diseases are even greater as the inability of implementing vector control strategies as has been reported in many countries [10]. Thus, it is extremely important to strengthen surveillance, control suspected cases of dengue, chikungunya and now Zika for early integrated detection of cases.…”

“…Thus, it is extremely important to strengthen surveillance, control suspected cases of dengue, chikungunya and now Zika for early integrated detection of cases. More joint efforts from Latin American countries are needed in addition to regional efforts of the Pan American Health Organization to provide and establish guidelines and policies [9]. There are more elements of concern in the current stage of Zika for Latin America, but a call for collaboration and search for health policies must exist, particularly in view of the increasing number of people travelling to and from Latin American countries [9].…”

Infections with biological therapy: strategies for risk minimization in tropical and developing countries

“…Here we present a possible algorithm (Figure 1) to confirm or rule out possible active or latent infections. Additional assessment on this general topic should be performed to consider other emerging tropical infectious disease pathogens, such as chikungunya and Zika [58][59][60], and their potential life-threatening implications in these clinical settings [60]. Finally, we should acknowledge that this review has limitations regarding the available evidence for some recommendations.…”